Results 151 to 160 of about 11,732 (171)

The evolving role of radiotherapy in oligometastatic pancreatic cancer: from palliation to disease-modifying multidisciplinary integration. [PDF]

Front Oncol
Zhang J, Shi S, Wu J, Tan Z, Liu F, Fang F, Zhen P.   +6 more
europepmc   +1 more source

Survival benefit of particle chemoradiotherapy in locally advanced unresectable pancreatic cancer: a systematic review and meta-analysis. [PDF]

Ther Adv Gastroenterol
Shieh CS, Cheng PL, Lai IC, Kao WY, Wu MH, Chiou JF, Wu PH, Lee HL.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Optimizing First-Line Chemotherapy in Metastatic Pancreatic Cancer: Efficacy of FOLFIRINOX versus Nab-Paclitaxel Plus Gemcitabine

Cancers, 2023
Elisa Giommoni, Lorenzo Antonuzzo
exaly  

Serum miR-373-3p and miR-194-5p Are Associated with Early Tumor Progression during FOLFIRINOX Treatment in Pancreatic Cancer Patients: A Prospective Multicenter Study

International Journal of Molecular Sciences, 2021
Hanneke Wilmink, Fleur van der Sijde, Thierry van den Bosch   +2 more
exaly  

Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis

Journal of the National Cancer Institute, 2019
Stephen Clarke, Alessandro Paniccia, Nathan Bahary   +2 more
exaly  

Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer

British Journal of Cancer, 2016
Yan-Hong Deng, Charles Cha, Jill Lacy
exaly  

Systematic review and meta-analysis of gemcitabine-based chemotherapy after FOLFIRINOX in advanced pancreatic cancer

Therapeutic Advances in Medical Oncology, 2020
Vinicius Fernando Calsavara, Victor H F de Jesus   +1 more
exaly  

FOLFIRINOX Chemotherapy in Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis of Retrospective and Phase II Studies

Journal of Clinical Medicine, 2018
Stephane Thibodeau, Ioannis A. Voutsadakis   +1 more
exaly  

Modified-FOLFIRINOX in metastatic pancreatic cancer: A prospective study in Chinese population

Cancer Letters, 2017
Xue-Li Bai, Ting-Bo Liang, Yun Zhang
exaly  

Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer

Journal of Surgical Oncology, 2013
Nathan Bahary, Brian A Boone
exaly